Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines

Journal of Neurochemistry

Volumn 107, Issue 3, 2008, Pages 855-870

  Vandell, Alexander G ^a   Larson, Nadya ^a   Laxmikanthan, Gurunathan ^b   Panos, Michael ^a   Blaber, Sachiko I ^b   Blaber, Michael ^b   Scarisbrick, Isobel A ^a,c  

^a MAYO CLINIC   (United States)

^b FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c MAYO CLINIC ROCHESTER   (United States)

Author keywords

Astrocyte; Bradykinin; Mitogen activated protein kinase; Neuron; Protease activated receptor; Protein kinase B

Indexed keywords

BRADYKININ B2 RECEPTOR; CALCIUM ION; KALLIKREIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; PROTEIN KLK1; PROTEINASE ACTIVATED RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN NERVE CELL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CALCIUM; CELL LINE; CENTRAL NERVOUS SYSTEM; KALLIKREINS; MICE; NEURONS; RECEPTORS, PROTEINASE-ACTIVATED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE KALLIKREINS;

EID: 53749092612     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05658.x     Document Type: Article

References (85)

1. Afkhami-Goli A., Noorbakhsh F., Keller A. J. et al. (2007) Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer's disease. J. Immunol. 179, 5493 5503.
2. Almonte A. G., Hamill C. E., Chhatwal J. P. et al. (2007) Learning and memory deficits in mice lacking protease activated receptor-1. Neurobiol. Learn. Mem. 88, 295 304.
3. Angelo P. F., Lima A. R., Alves F. M., Blaber S. I., Scarisbrick I. A., Blaber M., Juliano L. Juliano M. A. (2006) Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects. J. Biol. Chem. 281, 3116 3126.
4. Arthur P. G., Matich G. P., Pang W. W., Yu D. Y. Bogoyevitch M. A. (2007) Necrotic death of neurons following an excitotoxic insult is prevented by a peptide inhibitor of c-Jun N-terminal kinase. J. Neurochem. 102, 65 76.
5. Bernett M. J., Blaber S. I., Scarisbrick I. A., Dhanarajan P., Thompson S. M. Blaber M. (2002) Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system. J. Biol. Chem. 277, 24562 24570.
6. Bhoola K., Ramsaroop R., Plendl J., Cassim B., Dlamini Z. Naicker S. (2001) Kallikrein and kinin receptor expression in inflammation and cancer. Biol. Chem. 382, 77 89.
7. Biyashev D., Tan F., Chen Z., Zhang K., Deddish P. A., Erdos E. G. Hecquet C. (2006) Kallikrein activates bradykinin B2 receptors in absence of kininogen. Am. J. Physiol. Heart Circ. Physiol. 290, H1244 H1250.
8. Blaber S. I., Scarisbrick I. A., Bernett M. J., Dhanarajan P., Seavy M. A., Jin Y., Schwartz M. A., Rodriguez M. Blaber M. (2002) Enzymatic properties of rat myelencephalon-specific protease. Biochemistry 41, 1165 1173.
9. Blaber S. I., Ciric B., Christophi G. P., Bernett M. J., Blaber M., Rodriguez M. Scarisbrick I. A. (2004) Targeting kallikrein 6-proteolysis attenuates CNS inflammatory disease. FASEB J. 19, 920 922.
10. Borgono C. A. Diamandis E. P. (2004) The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876 890.
11. Borgono C. A., Gavigan J. A., Alves J., Bowles B., Harris J. L., Sotiropoulou G. Diamandis E. P. (2007) Defining the extended substrate specificity of kallikrein 1-related peptidases. Biol. Chem. 388, 1215 1225.
12. Boven L. A., Vergnolle N., Henry S. D., Silva C., Imai Y., Holden J., Warren K., Hollenberg M. D. Power C. (2003) Up-regulation of proteinase-activated receptor 1 expression in astrocytes during HIV encephalitis. J. Immunol. 170, 2638 2646.
13. Brunet A., Datta S. R. Greenberg M. E. (2001) Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol. 11, 297 305.
14. Bushell T. J., Plevin R., Cobb S. Irving A. J. (2006) Characterization of proteinase-activated receptor 2 signalling and expression in rat hippocampal neurons and astrocytes. Neuropharmacology 50, 714 725.
15. Cardin A. D., Witt K. R., Chao J., Margolius H. S., Donaldson V. H. Jackson R. L. (1984) Degradation of apolipoprotein B-100 of human plasma low density lipoproteins by tissue and plasma kallikreins. J. Biol. Chem. 259, 8522 8528.
16. Chao J. Chao L. (2006) Experimental therapy with tissue kallikrein against cerebral ischemia. Front Biosci. 11, 1323 1327.
17. Choi B. H., Kim R. C., Vaughan P. J., Lau A., Van Nostrand W. E., Cotman C. W. Cunningham D. D. (1995) Decreases in protease nexins in Alzheimer's disease brain. Neurobiol. Aging 16, 557 562.
18. Choi S. H., Joe E. H., Kim S. U. Jin B. K. (2003) Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo. J. Neurosci. 23, 5877 5886.
19. Choi J. S., Park H. J., Kim H. Y., Kim S. Y., Lee J. E., Choi Y. S., Chun M. H., Chung J. W. Lee M. Y. (2005) Phosphorylation of PTEN and Akt in astrocytes of the rat hippocampus following transient forebrain ischemia. Cell Tissue Res. 319, 359 366.
20. Christophi G. P., Isackson P. J., Blaber S. I., Blaber M., Rodriguez M. Scarisbrick I. A. (2004) Distinct promoters regulate tissue-specific and differential expression of kallikrein 6 in CNS demyelinating disease. J. Neurochem. 91, 1439 1449.
21. Citron B. A., Smirnova I. V., Arnold P. M. Festoff B. W. (2000) Upregulation of neurotoxic serine proteases, prothrombin, and protease-activated receptor 1 early after spinal cord injury. J. Neurotrauma 17, 1191 1203.
22. Clements J., Hooper J., Dong Y. Harvey T. (2001) The expanded human kallikrein (KLK) gene family: genomic organization, tissue-specific expression and potential functions. Biol. Chem. 382, 5 14.
23. Eggett C. J., Crosier S., Manning P., Cookson M. R., Menzies F. M., McNeil C. J. Shaw P. J. (2000) Development and characterisation of a glutamate-sensitive motor neurone cell line. J. Neurochem. 74, 1895 1902.
24. Festoff B. W., ed 1992) Protease Cascade Dysregulation and Synaptic Degeneration in Amyotrophic Lateral Sclerosis, pp. 621 685. Marcel Dekker, New York.
25. Fok-Seang J., Smith-Thomas L. C., Meiners S. et al. (1995) An analysis of astrocytic cell lines with different abilities to promote axon growth. Brain Res. 689, 207 223.
26. Gingrich M. B., Junge C. E., Lyuboslavsky P. Traynelis S. F. (2000) Potentiation of NMDA receptor function by the serine protease thrombin. J. Neurosci. 20, 4582 4595.
27. Groger M., Lebesgue D., Pruneau D., Relton J., Kim S. W., Nussberger J. Plesnila N. (2005) Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 25, 978 989.
28. Hamill C. E., Caudle W. M., Richardson J. R., Yuan H., Pennell K. D., Greene J. G., Miller G. W. Traynelis S. F. (2007) Exacerbation of dopaminergic terminal damage in a mouse model of Parkinson's disease by the G-protein-coupled receptor protease-activated receptor 1. Mol. Pharmacol. 72, 653 664.
29. Hecquet C., Biyashev D., Tan F. Erdos E. G. (2006) Positive cooperativity between the thrombin and bradykinin B2 receptors enhances arachidonic acid release. Am. J. Physiol. Heart Circ. Physiol. 290, H948 H958.
30. Hellal F., Pruneau D., Palmier B., Faye P., Croci N., Plotkine M. Marchand-Verrecchia C. (2003) Detrimental role of bradykinin B2 receptor in a murine model of diffuse brain injury. J. Neurotrauma 20, 841 851.
31. Houle S., Molinaro G., Adam A. Marceau F. (2003) Tissue kallikrein actions at the rabbit natural or recombinant kinin B2 receptors. Hypertension 41, 611 617.
32. Jalink K. Moolenaar W. H. (1992) Thrombin receptor activation causes rapid neural cell rounding and neurite retraction independent of classic second messengers. J. Cell Biol. 118, 411 419.
33. Jiang Y., Wu J., Hua Y., Keep R. F., Xiang J., Hoff J. T. Xi G. (2002) Thrombin-receptor activation and thrombin-induced brain tolerance. J. Cereb. Blood Flow Metab. 22, 404 410.
34. Junge C. E., Sugawara T., Mannaioni G., Alagarsamy S., Conn P. J., Brat D. J., Chan P. H. Traynelis S. F. (2003) The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia. Proc. Natl Acad. Sci. USA 100, 13019 13024.
35. Junge C. E., Lee C. J., Hubbard K. B., Zhang Z., Olson J. J., Hepler J. R., Brat D. J. Traynelis S. F. (2004) Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes. Exp. Neurol. 188, 94 103.
36. Kitaoka T., Hua Y., Xi G., Hoff J. T. Keep R. F. (2002) Delayed argatroban treatment reduces edema in a rat model of intracerebral hemorrhage. Stroke 33, 3012 3018.
37. Laxmikanthan G., Blaber S. I., Bernett M. J., Scarisbrick I. A., Juliano M. A. Blaber M. (2005) 1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding. Proteins 58, 802 814.
38. Lee K. R., Drury I., Vitarbo E. Hoff J. T. (1997) Seizures induced by intracerebral injection of thrombin: a model of intracerebral hemorrhage. J. Neurosurg. 87, 73 78.
39. Lehmberg J., Beck J., Baethmann A. Uhl E. (2003) Bradykinin antagonists reduce leukocyte-endothelium interactions after global cerebral ischemia. J. Cereb. Blood Flow Metab. 23, 441 448.
40. Little S. P., Dixon E. P., Norris F. et al. (1997) Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain. J. Biol. Chem. 272, 25135 25142.
41. Liu Y., Fields R. D., Festoff B. W. Nelson P. G. (1994) Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction. Proc. Natl Acad. Sci. USA 91, 10300 10304.
42. Lorenzl S., Kodel U., Frei K. Pfister H. W. (1996) Effect of the bradykinin B2 receptor antagonist Hoe140 in experimental pneumococcal meningitis in the rat. Eur. J. Pharmacol. 308, 335 341.
43. Luo W., Wang Y., Hanck T., Stricker R. Reiser G. (2006) Jab1, a novel protease-activated receptor-2 (PAR-2)-interacting protein, is involved in PAR-2-induced activation of activator protein-1. J. Biol. Chem. 281, 7927 7936.
44. McLaughlin B. A., Nelson D., Silver I. A., Erecinska M. Chesselet M. F. (1998) Methylmalonate toxicity in primary neuronal cultures. Neuroscience 86, 279 290.
45. Monard D. (1988) Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth. Trends Neurosci. 11, 541 544.
46. Neary J. T., Kang Y., Tran M. Feld J. (2005) Traumatic injury activates protein kinase B/Akt in cultured astrocytes: role of extracellular ATP and P2 purinergic receptors. J. Neurotrauma 22, 491 500.
47. Nicole O., Goldshmidt A., Hamill C. E., Sorensen S. D., Sastre A., Lyuboslavsky P., Hepler J. R., McKeon R. J. Traynelis S. F. (2005) Activation of protease-activated receptor-1 triggers astrogliosis after brain injury. J. Neurosci. 25, 4319 4329.
48. Nishino A., Suzuki M., Ohtani H., Motohashi O., Umezawa K., Nagura H. Yoshimoto T. (1993) Thrombin may contribute to the pathophysiology of central nervous system injury. J. Neurotrauma 10, 167 179.
49. Noorbakhsh F., Tsutsui S., Vergnolle N. et al. (2006) Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Exp. Med. 203, 425 435.
50. Oikonomopoulou K., Hansen K. K., Saifeddine M. et al. (2006a) Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs). Biol. Chem. 387, 817 824.
51. Oikonomopoulou K., Hansen K. K., Saifeddine M. et al. (2006b) Proteinase-activated receptors, targets for kallikrein signaling. J. Biol. Chem. 281, 32095 32112.
52. Ole-MoiYoi O. K., Pinkus G. S., Spragg J. Austen K. F. (1979) Identification of human glandular kallikrein in the beta cell of the pancreas. N. Engl. J. Med. 300, 1289 1294.
53. Park G. H., Ryu J. R., Shin C. Y., Choi M. S., Han B. H., Kim W. K., Kim H. C. Ko K. H. (2006) Evidence that protease-activated receptor-2 mediates trypsin-induced reversal of stellation in cultured rat astrocytes. Neurosci. Res. 54, 15 23.
54. Raidoo D. M., Ramsaroop R., Naidoo S. Bhoola K. D. (1996) Regional distribution of tissue kallikrein in the human brain. Immunopharmacology 32, 39 47.
55. Riek-Burchardt M., Striggow F., Henrich-Noack P., Reiser G. Reymann K. G. (2002) Increase of prothrombin-mRNA after global cerebral ischemia in rats, with constant expression of protease nexin-1 and protease-activated receptors. Neurosci. Lett. 329, 181 184.
56. Rohatgi T., Henrich-Noack P., Sedehizade F., Goertler M., Wallesch C. W., Reymann K. G. Reiser G. (2004) Transient focal ischemia in rat brain differentially regulates mRNA expression of protease-activated receptors 1 to 4. J. Neurosci. Res. 75, 273 279.
57. Scarisbrick I. A., Towner M. D. Isackson P. J. (1997) Nervous system specific expression of a novel serine protease: regulation in the adult rat spinal cord by excitotoxic injury. J. Neurosci. 17, 8156 8168.
58. Scarisbrick I. A., Asakura K., Blaber S., Blaber M., Isackson P. J., Bieto T., Rodriguez M. Windebank A. J. (2000) Preferential expression of myelencephalon-specific protease by oligodendrocytes of the adult rat spinal cord white matter. Glia 30, 219 230.
59. Scarisbrick I. A., Isackson P. J., Ciric B., Windebank A. J. Rodriguez M. (2001) MSP, a trypsin-like serine protease, is abundantly expressed in the human nervous system. J. Comp. Neurol. 431, 347 361.
60. Scarisbrick I. A., Blaber S. I., Lucchinetti C. F., Genain C. P., Blaber M. Rodriguez M. (2002) Activity of a newly identified serine protease in CNS demyelination. Brain 125, 1283 1296.
61. Scarisbrick I. A., Blaber S. I., Tingling J. T., Rodriguez M., Blaber M. Christophi G. P. (2006a) Potential scope of action of tissue kallikreins in CNS immune-mediated disease. J. Neuroimmunol. 178, 167 176.
62. Scarisbrick I. A., Sabharwal P., Cruz H. et al. (2006b) Dynamic role of kallikrein 6 in traumatic spinal cord injury. Eur. J. Neurosci. 24, 1457 1469.
63. Scarisbrick I. A., Linbo R. Vandell A., et al. (2008) Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration. Biol. Chem. 389, 739 745.
64. Seeds N. W., Haffke S., Christensen K. Schoonmaker J. (1990) Cerebellar granule cell migration involves proteolysis. Adv. Exp. Med. Biol. 265, 169 178.
65. Selcher J. C., Weeber E. J., Christian J., Nekrasova T., Landreth G. E. Sweatt J. D. (2003) A role for ERK MAP kinase in physiologic temporal integration in hippocampal area CA1. Learn. Mem. 10, 26 39.
66. Siconolfi L. B. Seeds N. W. (2001) Induction of the plasminogen activator system accompanies peripheral nerve regeneration after sciatic nerve crush. J. Neurosci. 21, 4336 4347.
67. Smirnova I. V., Citron B. A., Arnold P. M. Festoff B. W. (2001) Neuroprotective signal transduction in model motor neurons exposed to thrombin: G-protein modulation effects on neurite outgrowth, Ca(2+) mobilization, and apoptosis. J. Neurobiol. 48, 87 100.
68. Smith-Swintosky V. L., Cheo-Isaacs C. T., D'Andrea M. R., Santulli R. J., Darrow A. L. Andrade-Gordon P. (1997) Protease-activated receptor-2 (PAR-2) is present in the rat hippocampus and is associated with neurodegeneration. J. Neurochem. 69, 1890 1896.
69. Sorensen S. D., Nicole O., Peavy R. D., Montoya L. M., Lee C. J., Murphy T. J., Traynelis S. F. Hepler J. R. (2003) Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes. Mol. Pharmacol. 64, 1199 1209.
70. Steinhoff M., Vergnolle N., Young S. H. et al. (2000) Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat. Med. 6, 151 158.
71. Steinhoff M., Buddenkotte J., Shpacovitch V., Rattenholl A., Moormann C., Vergnolle N., Luger T. A. Hollenberg M. D. (2005) Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr. Rev. 26, 1 43.
72. Striggow F., Riek M., Breder J., Henrich-Noack P., Reymann K. G. Reiser G. (2000) The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc. Natl Acad. Sci. USA 97, 2264 2269.
73. Suo Z., Wu M., Ameenuddin S., Anderson H. E., Zoloty J. E., Citron B. A., Andrade-Gordon P. Festoff B. W. (2002) Participation of protease-activated receptor-1 in thrombin-induced microglial activation. J. Neurochem. 80, 655 666.
74. Terayama R., Bando Y., Takahashi T. Yoshida S. (2004) Differential expression of neuropsin and protease M/neurosin in oligodendrocytes after injury to the spinal cord. Glia 48, 91 101.
75. Tsirka S. E., Rogove A. D., Bugge T. H., Degen J. L. Strickland S. (1997) An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J. Neurosci. 17, 543 552.
76. Uchida A., Oka Y., Aoyama M. et al. (2004) Expression of myelencephalon-specific protease in transient middle cerebral artery occlusion model of rat brain. Mol. Brain Res. 126, 129 136.
77. Vergnolle N., Bunnett N. W., Sharkey K. A. et al. (2001) Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat. Med. 7, 821 826.
78. Wang H., Ubl J. J. Reiser G. (2002a) Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling. Glia 37, 53 63.
79. Wang H., Ubl J. J., Stricker R. Reiser G. (2002b) Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways. Am. J. Physiol. Cell Physiol. 283, C1351 C1364.
80. Wang Y., Luo W. Reiser G. (2007) Proteinase-activated receptor-1 and -2 induce the release of chemokine GRO/CINC-1 from rat astrocytes via differential activation of JNK isoforms, evoking multiple protective pathways in brain. Biochem. J. 401, 65 78.
81. Weinstein J. R., Gold S. J., Cunningham D. D. Gall C. M. (1995) Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J. Neurosci. 15, 2906 2919.
82. Xia C. F., Yin H., Borlongan C. V., Chao L. Chao J. (2004) Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension 43, 452 459.
83. Xue M. Del Bigio M. R. (2001) Acute tissue damage after injections of thrombin and plasmin into rat striatum. Stroke 32, 2164 2169.
84. Yoon H., Laxmikanthan G., Lee J., Blaber S. I., Rodriguez A., Kogot J. M., Scarisbrick I. A. Blaber M. (2007) Activation profiles and regulatory cascades of the human kallikrein-related peptidases. J. Biol. Chem. 282, 31852 31864.
85. Zarghooni M., Soosaipillai A., Grass L., Scorilas A., Mirazimi N. Diamandis E. P. (2002) Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients. Clin. Biochem. 35, 225 231.